David Weinberg over at Science-Based Medicine has his part two of a deep dive into the so-called SCOTS trial, which is a non-traditional pay-for-play study. I highly recommend it.
SCOTS trial under the magnifying glass
In this piece, Weinberg provides interesting background on the two people running SCOTS. I’ve had many concerns about the SCOTS “trial” over the years. See my most recent piece where I posted questions I thought I would have answers to with a planned interview with SCOTS. But it never happened.
Weinberg also provides new info on an investigation by The American Academy of Ophthalmology (AAO).
To me, the situation with AAO just raises more concerns.
- Engineering a niche supporting hematopoietic stem cell development using integrated single-cell transcriptomics, Nat. Comm.
- Functional redundancy among Polycomb complexes in maintaining the pluripotent state of embryonic stem cells, Stem Cell Reports.
- The Human Motoneuron Expression Signature is Defined by ALS-Related Genes, BioRxiv
- Chance discovery could lead to a treatment for skin ulcers, CIRM Blog.
- Patients Seeking stem cell therapies — a Prospective qualitative analysis from a Regenerative Medicine Consult Service
Nature npc Regenerative Medicine.
- The map of our DNA is finally complete. Here’s what that means for humanity, USA Today. From the wonderful Karen Weintraub. This isn’t the first time or maybe even the second time it’s been said the human genome is “done”. I bet there are still novel sequences to be found, especially in all those repeat regions in our genomes. However, this is great work. It’s also cool that UC Davis had a role in this effort.